Randomized Controlled Study Investigating Viral Suppression and Serological Response following PreS 1 / PreS 2 / S Vaccine Therapy Combined with Lamivudine Treatment in HBeAg-Positive Patients with Chronic Hepatitis B
Randomized Controlled Study Investigating Viral Suppression and Serological Response following Pre-S1/Pre-S2/S Vaccine Therapy Combined with Lamivudine Treatment in HBeAg-Positive Patients with Chronic Hepatitis B Pham Thi Le Hoa,* Nguyen Tien Huy, Le The Thu, Cao Ngoc Nga, Kazuhiko Nakao, Katsumi Eguchi, Nguyen Huu Chi, Bui Huu Hoang, and Kenji Hirayama* Department of Infectious Diseases and Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, and The Hospital for Tropical Diseases, Ho Chi Minh City, and University of Medicine at Can Tho City, Can Tho City, Vietnam, and Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Department of Internal Medicine, and Center for International Collaborative Research, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, and Global COE Program, Nagasaki University, Nagasaki, Japan